South Korea Immunoassay Market Size, Share, Trends and Forecast by Technology, Product, Application, End Use, and Region, 2026-2034
The South Korea immunoassay market size reached USD 650.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 968.2 Million by 2034, exhibiting a growth rate (CAGR) of 4.38% during 2026-2034. The increasing prevalence of chronic diseases and infectious conditions in South Korea is driving the demand for accurate diagnostic tools like immunoassays, particularly with the aging population. Additionally, the rapid growth of digital health and telemedicine services, which requires remote diagnostic solutions, is further contributing to the expansion of the South Korea immunoassay market share.
SOUTH KOREA IMMUNOASSAY MARKET TRENDS:
Rising Incidence of Chronic Diseases and Infectious Conditions
The growing prevalence of chronic illnesses like cancer, diabetes, and heart diseases is considerably driving the need for dependable diagnostic tests in South Korea. Immunoassays are becoming an essential method for identifying biomarkers associated with these conditions, providing precise and effective results. With the country's aging population intensifying the pressure on the healthcare system, early diagnosis and treatment are becoming critical. As per the 2024 Statistics on the Aged, those who are 65 years old and older constitute 19.2% of the population, a percentage anticipated to rise beyond 20% by 2025 and attain 30% by 2036. This demographic shift is contributing to a higher incidence of age-related diseases, putting additional strain on healthcare resources and increasing the need for effective diagnostic solutions. Moreover, infectious diseases continue to be a constant public health issue, catalyzing the demand for accurate diagnostic instruments. Immunoassays play a crucial role in identifying pathogens and controlling disease outbreaks, guaranteeing prompt recognition of infectious agents. The dual burden of chronic illnesses and infectious diseases highlights the importance of dependable and accessible diagnostic tests, such as immunoassays, which are crucial in South Korea's healthcare system, especially for controlling disease transmission and enhancing patient results. This rising demand for immunoassays to address changing healthcare challenges is significantly contributing to the South Korea immunoassay market growth.
Increasing Investments in Digital Health and Telemedicine
The swift growth of digital health technologies and telemedicine services in South Korea is creating substantial demand for remote diagnostic instruments, such as immunoassays. As virtual consultations and remote patient monitoring gain more attention, telemedicine platforms are incorporating diagnostic tools like immunoassays to deliver quick, precise test results without the need for in-person appointments. This transition towards digital healthcare options is increasing access to prompt medical services, especially in rural and disadvantaged regions where healthcare resources might be scarce. The growing use of telemedicine in South Korea is evidenced by the nation's telemedicine market, which attained a worth of USD 1,744.4 million in 2024. With the rise of telemedicine, there is a significant need for incorporating diagnostic technologies that are readily accessible and usable from a distance. Immunoassays, which are being more frequently integrated into telemedicine platforms, allow healthcare providers to deliver more thorough care to patients remotely. This integration improves the overall effectiveness of healthcare services, enabling quicker diagnoses and better management of different health issues. As the telemedicine sector continues to grow, immunoassays are emerging as an essential part of South Korea’s healthcare system, enhancing patient results by delivering precise diagnostics instantly, including for individuals lacking immediate access to conventional medical facilities.
SOUTH KOREA IMMUNOASSAY MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2026-2034. Our report has categorized the market based on technology, product, application, and end use.
Technology Insights:
Product Insights:
Application Insights:
End Use Insights:
Regional Insights:
COMPETITIVE LANDSCAPE:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea immunoassay market performed so far and how will it perform in the coming years?
What is the breakup of the South Korea immunoassay market on the basis of product?
What is the breakup of the South Korea immunoassay market on the basis of technology?
What is the breakup of the South Korea immunoassay market on the basis of application?
What is the breakup of the South Korea immunoassay market on the basis of end use?
What is the breakup of the South Korea immunoassay market on the basis of region?
What are the various stages in the value chain of the South Korea immunoassay market?
What are the key driving factors and challenges in the South Korea immunoassay market?
What is the structure of the South Korea immunoassay market and who are the key players?
What is the degree of competition in the South Korea immunoassay market?
SOUTH KOREA IMMUNOASSAY MARKET TRENDS:
Rising Incidence of Chronic Diseases and Infectious Conditions
The growing prevalence of chronic illnesses like cancer, diabetes, and heart diseases is considerably driving the need for dependable diagnostic tests in South Korea. Immunoassays are becoming an essential method for identifying biomarkers associated with these conditions, providing precise and effective results. With the country's aging population intensifying the pressure on the healthcare system, early diagnosis and treatment are becoming critical. As per the 2024 Statistics on the Aged, those who are 65 years old and older constitute 19.2% of the population, a percentage anticipated to rise beyond 20% by 2025 and attain 30% by 2036. This demographic shift is contributing to a higher incidence of age-related diseases, putting additional strain on healthcare resources and increasing the need for effective diagnostic solutions. Moreover, infectious diseases continue to be a constant public health issue, catalyzing the demand for accurate diagnostic instruments. Immunoassays play a crucial role in identifying pathogens and controlling disease outbreaks, guaranteeing prompt recognition of infectious agents. The dual burden of chronic illnesses and infectious diseases highlights the importance of dependable and accessible diagnostic tests, such as immunoassays, which are crucial in South Korea's healthcare system, especially for controlling disease transmission and enhancing patient results. This rising demand for immunoassays to address changing healthcare challenges is significantly contributing to the South Korea immunoassay market growth.
Increasing Investments in Digital Health and Telemedicine
The swift growth of digital health technologies and telemedicine services in South Korea is creating substantial demand for remote diagnostic instruments, such as immunoassays. As virtual consultations and remote patient monitoring gain more attention, telemedicine platforms are incorporating diagnostic tools like immunoassays to deliver quick, precise test results without the need for in-person appointments. This transition towards digital healthcare options is increasing access to prompt medical services, especially in rural and disadvantaged regions where healthcare resources might be scarce. The growing use of telemedicine in South Korea is evidenced by the nation's telemedicine market, which attained a worth of USD 1,744.4 million in 2024. With the rise of telemedicine, there is a significant need for incorporating diagnostic technologies that are readily accessible and usable from a distance. Immunoassays, which are being more frequently integrated into telemedicine platforms, allow healthcare providers to deliver more thorough care to patients remotely. This integration improves the overall effectiveness of healthcare services, enabling quicker diagnoses and better management of different health issues. As the telemedicine sector continues to grow, immunoassays are emerging as an essential part of South Korea’s healthcare system, enhancing patient results by delivering precise diagnostics instantly, including for individuals lacking immediate access to conventional medical facilities.
SOUTH KOREA IMMUNOASSAY MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2026-2034. Our report has categorized the market based on technology, product, application, and end use.
Technology Insights:
- Radioimmunoassay
- Enzyme Immunoassay
- Rapid Test
- Others
Product Insights:
- Reagents and Kits
- Analyzers/Instruments
- Software and Services
Application Insights:
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
End Use Insights:
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
Regional Insights:
- Seoul Capital Area
- Yeongnam (Southeastern Region)
- Honam (Southwestern Region)
- Hoseo (Central Region)
- Others
COMPETITIVE LANDSCAPE:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea immunoassay market performed so far and how will it perform in the coming years?
What is the breakup of the South Korea immunoassay market on the basis of product?
What is the breakup of the South Korea immunoassay market on the basis of technology?
What is the breakup of the South Korea immunoassay market on the basis of application?
What is the breakup of the South Korea immunoassay market on the basis of end use?
What is the breakup of the South Korea immunoassay market on the basis of region?
What are the various stages in the value chain of the South Korea immunoassay market?
What are the key driving factors and challenges in the South Korea immunoassay market?
What is the structure of the South Korea immunoassay market and who are the key players?
What is the degree of competition in the South Korea immunoassay market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA IMMUNOASSAY MARKET - INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 SOUTH KOREA IMMUNOASSAY MARKET LANDSCAPE
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 SOUTH KOREA IMMUNOASSAY MARKET - BREAKUP BY TECHNOLOGY
6.1 Radioimmunoassay
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Forecast (2026-2034)
6.2 Enzyme Immunoassay
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Forecast (2026-2034)
6.3 Rapid Test
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2020-2025)
6.3.3 Market Forecast (2026-2034)
6.4 Others
6.4.1 Historical and Current Market Trends (2020-2025)
6.4.2 Market Forecast (2026-2034)
7 SOUTH KOREA IMMUNOASSAY MARKET - BREAKUP BY PRODUCT
7.1 Reagents and Kits
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (2026-2034)
7.2 Analyzers/Instruments
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Forecast (2026-2034)
7.3 Software and Services
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2020-2025)
7.3.3 Market Forecast (2026-2034)
8 SOUTH KOREA IMMUNOASSAY MARKET - BREAKUP BY APPLICATION
8.1 Therapeutic Drug Monitoring
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Forecast (2026-2034)
8.2 Oncology
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Forecast (2026-2034)
8.3 Cardiology
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Forecast (2026-2034)
8.4 Endocrinology
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2020-2025)
8.4.3 Market Forecast (2026-2034)
8.5 Infectious Disease Testing
8.5.1 Overview
8.5.2 Historical and Current Market Trends (2020-2025)
8.5.3 Market Forecast (2026-2034)
8.6 Autoimmune Diseases
8.6.1 Overview
8.6.2 Historical and Current Market Trends (2020-2025)
8.6.3 Market Forecast (2026-2034)
8.7 Others
8.7.1 Historical and Current Market Trends (2020-2025)
8.7.2 Market Forecast (2026-2034)
9 SOUTH KOREA IMMUNOASSAY MARKET - BREAKUP BY END USE
9.1 Hospitals
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2020-2025)
9.1.3 Market Forecast (2026-2034)
9.2 Blood Banks
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2020-2025)
9.2.3 Market Forecast (2026-2034)
9.3 Clinical Laboratories
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2020-2025)
9.3.3 Market Forecast (2026-2034)
9.4 Pharmaceutical and Biotech Companies
9.4.1 Overview
9.4.2 Historical and Current Market Trends (2020-2025)
9.4.3 Market Forecast (2026-2034)
9.5 Academic Research Centers
9.5.1 Overview
9.5.2 Historical and Current Market Trends (2020-2025)
9.5.3 Market Forecast (2026-2034)
9.6 Others
9.6.1 Historical and Current Market Trends (2020-2025)
9.6.2 Market Forecast (2026-2034)
10 SOUTH KOREA IMMUNOASSAY MARKET – BREAKUP BY REGION
10.1 Seoul Capital Area
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2020-2025)
10.1.3 Market Breakup by Technology
10.1.4 Market Breakup by Product
10.1.5 Market Breakup by Application
10.1.6 Market Breakup by End Use
10.1.7 Key Players
10.1.8 Market Forecast (2026-2034)
10.2 Yeongnam (Southeastern Region)
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2020-2025)
10.2.3 Market Breakup by Technology
10.2.4 Market Breakup by Product
10.2.5 Market Breakup by Application
10.2.6 Market Breakup by End Use
10.2.7 Key Players
10.2.8 Market Forecast (2026-2034)
10.3 Honam (Southwestern Region)
10.3.1 Overview
10.3.2 Historical and Current Market Trends (2020-2025)
10.3.3 Market Breakup by Technology
10.3.4 Market Breakup by Product
10.3.5 Market Breakup by Application
10.3.6 Market Breakup by End Use
10.3.7 Key Players
10.3.8 Market Forecast (2026-2034)
10.4 Hoseo (Central Region)
10.4.1 Overview
10.4.2 Historical and Current Market Trends (2020-2025)
10.4.3 Market Breakup by Technology
10.4.4 Market Breakup by Product
10.4.5 Market Breakup by Application
10.4.6 Market Breakup by End Use
10.4.7 Key Players
10.4.8 Market Forecast (2026-2034)
10.5 Others
10.5.1 Historical and Current Market Trends (2020-2025)
10.5.2 Market Forecast (2026-2034)
11 SOUTH KOREA IMMUNOASSAY MARKET – COMPETITIVE LANDSCAPE
11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant
12 PROFILES OF KEY PLAYERS
12.1 Company A
12.1.1 Business Overview
12.1.2 Products Offered
12.1.3 Business Strategies
12.1.4 SWOT Analysis
12.1.5 Major News and Events
12.2 Company B
12.2.1 Business Overview
12.2.2 Products Offered
12.2.3 Business Strategies
12.2.4 SWOT Analysis
12.2.5 Major News and Events
12.3 Company C
12.3.1 Business Overview
12.3.2 Products Offered
12.3.3 Business Strategies
12.3.4 SWOT Analysis
12.3.5 Major News and Events
12.4 Company D
12.4.1 Business Overview
12.4.2 Products Offered
12.4.3 Business Strategies
12.4.4 SWOT Analysis
12.4.5 Major News and Events
12.5 Company E
12.5.1 Business Overview
12.5.2 Products Offered
12.5.3 Business Strategies
12.5.4 SWOT Analysis
12.5.5 Major News and Events
13 SOUTH KOREA IMMUNOASSAY MARKET - INDUSTRY ANALYSIS
13.1 Drivers, Restraints, and Opportunities
13.1.1 Overview
13.1.2 Drivers
13.1.3 Restraints
13.1.4 Opportunities
13.2 Porters Five Forces Analysis
13.2.1 Overview
13.2.2 Bargaining Power of Buyers
13.2.3 Bargaining Power of Suppliers
13.2.4 Degree of Competition
13.2.5 Threat of New Entrants
13.2.6 Threat of Substitutes
13.3 Value Chain Analysis
14 APPENDIX
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA IMMUNOASSAY MARKET - INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 SOUTH KOREA IMMUNOASSAY MARKET LANDSCAPE
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 SOUTH KOREA IMMUNOASSAY MARKET - BREAKUP BY TECHNOLOGY
6.1 Radioimmunoassay
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Forecast (2026-2034)
6.2 Enzyme Immunoassay
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Forecast (2026-2034)
6.3 Rapid Test
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2020-2025)
6.3.3 Market Forecast (2026-2034)
6.4 Others
6.4.1 Historical and Current Market Trends (2020-2025)
6.4.2 Market Forecast (2026-2034)
7 SOUTH KOREA IMMUNOASSAY MARKET - BREAKUP BY PRODUCT
7.1 Reagents and Kits
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (2026-2034)
7.2 Analyzers/Instruments
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Forecast (2026-2034)
7.3 Software and Services
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2020-2025)
7.3.3 Market Forecast (2026-2034)
8 SOUTH KOREA IMMUNOASSAY MARKET - BREAKUP BY APPLICATION
8.1 Therapeutic Drug Monitoring
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Forecast (2026-2034)
8.2 Oncology
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Forecast (2026-2034)
8.3 Cardiology
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Forecast (2026-2034)
8.4 Endocrinology
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2020-2025)
8.4.3 Market Forecast (2026-2034)
8.5 Infectious Disease Testing
8.5.1 Overview
8.5.2 Historical and Current Market Trends (2020-2025)
8.5.3 Market Forecast (2026-2034)
8.6 Autoimmune Diseases
8.6.1 Overview
8.6.2 Historical and Current Market Trends (2020-2025)
8.6.3 Market Forecast (2026-2034)
8.7 Others
8.7.1 Historical and Current Market Trends (2020-2025)
8.7.2 Market Forecast (2026-2034)
9 SOUTH KOREA IMMUNOASSAY MARKET - BREAKUP BY END USE
9.1 Hospitals
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2020-2025)
9.1.3 Market Forecast (2026-2034)
9.2 Blood Banks
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2020-2025)
9.2.3 Market Forecast (2026-2034)
9.3 Clinical Laboratories
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2020-2025)
9.3.3 Market Forecast (2026-2034)
9.4 Pharmaceutical and Biotech Companies
9.4.1 Overview
9.4.2 Historical and Current Market Trends (2020-2025)
9.4.3 Market Forecast (2026-2034)
9.5 Academic Research Centers
9.5.1 Overview
9.5.2 Historical and Current Market Trends (2020-2025)
9.5.3 Market Forecast (2026-2034)
9.6 Others
9.6.1 Historical and Current Market Trends (2020-2025)
9.6.2 Market Forecast (2026-2034)
10 SOUTH KOREA IMMUNOASSAY MARKET – BREAKUP BY REGION
10.1 Seoul Capital Area
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2020-2025)
10.1.3 Market Breakup by Technology
10.1.4 Market Breakup by Product
10.1.5 Market Breakup by Application
10.1.6 Market Breakup by End Use
10.1.7 Key Players
10.1.8 Market Forecast (2026-2034)
10.2 Yeongnam (Southeastern Region)
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2020-2025)
10.2.3 Market Breakup by Technology
10.2.4 Market Breakup by Product
10.2.5 Market Breakup by Application
10.2.6 Market Breakup by End Use
10.2.7 Key Players
10.2.8 Market Forecast (2026-2034)
10.3 Honam (Southwestern Region)
10.3.1 Overview
10.3.2 Historical and Current Market Trends (2020-2025)
10.3.3 Market Breakup by Technology
10.3.4 Market Breakup by Product
10.3.5 Market Breakup by Application
10.3.6 Market Breakup by End Use
10.3.7 Key Players
10.3.8 Market Forecast (2026-2034)
10.4 Hoseo (Central Region)
10.4.1 Overview
10.4.2 Historical and Current Market Trends (2020-2025)
10.4.3 Market Breakup by Technology
10.4.4 Market Breakup by Product
10.4.5 Market Breakup by Application
10.4.6 Market Breakup by End Use
10.4.7 Key Players
10.4.8 Market Forecast (2026-2034)
10.5 Others
10.5.1 Historical and Current Market Trends (2020-2025)
10.5.2 Market Forecast (2026-2034)
11 SOUTH KOREA IMMUNOASSAY MARKET – COMPETITIVE LANDSCAPE
11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant
12 PROFILES OF KEY PLAYERS
12.1 Company A
12.1.1 Business Overview
12.1.2 Products Offered
12.1.3 Business Strategies
12.1.4 SWOT Analysis
12.1.5 Major News and Events
12.2 Company B
12.2.1 Business Overview
12.2.2 Products Offered
12.2.3 Business Strategies
12.2.4 SWOT Analysis
12.2.5 Major News and Events
12.3 Company C
12.3.1 Business Overview
12.3.2 Products Offered
12.3.3 Business Strategies
12.3.4 SWOT Analysis
12.3.5 Major News and Events
12.4 Company D
12.4.1 Business Overview
12.4.2 Products Offered
12.4.3 Business Strategies
12.4.4 SWOT Analysis
12.4.5 Major News and Events
12.5 Company E
12.5.1 Business Overview
12.5.2 Products Offered
12.5.3 Business Strategies
12.5.4 SWOT Analysis
12.5.5 Major News and Events
13 SOUTH KOREA IMMUNOASSAY MARKET - INDUSTRY ANALYSIS
13.1 Drivers, Restraints, and Opportunities
13.1.1 Overview
13.1.2 Drivers
13.1.3 Restraints
13.1.4 Opportunities
13.2 Porters Five Forces Analysis
13.2.1 Overview
13.2.2 Bargaining Power of Buyers
13.2.3 Bargaining Power of Suppliers
13.2.4 Degree of Competition
13.2.5 Threat of New Entrants
13.2.6 Threat of Substitutes
13.3 Value Chain Analysis
14 APPENDIX
